Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: A cause for concern?

Frank Firkin

doi:10.3109/10428194.2013.856429

Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: A cause for concern?

Frank Firkin

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	977-978
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	55
Issue number	5
DOIs	https://doi.org/10.3109/10428194.2013.856429
Publication status	Published - 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2013.856429

Cite this

@article{28f075a8bfbb400ea073ba7323675de1,

title = "Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: A cause for concern?",

author = "Frank Firkin",

year = "2014",

doi = "10.3109/10428194.2013.856429",

language = "English",

volume = "55",

pages = "977--978",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor \& Francis",

number = "5",

}

TY - JOUR

T1 - Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide

T2 - A cause for concern?

AU - Firkin, Frank

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84899769430

U2 - 10.3109/10428194.2013.856429

DO - 10.3109/10428194.2013.856429

M3 - Comment / Debate

AN - SCOPUS:84899769430

SN - 1042-8194

VL - 55

SP - 977

EP - 978

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 5

ER -

Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: A cause for concern?

UN SDGs

Access to Document

Other files and links

Cite this